<DOC>
	<DOCNO>NCT00389519</DOCNO>
	<brief_summary>The primary purpose study evaluate blood pressure lower effect ramipril , FDA-approved drug treatment hypertension adult , child adolescent age 6 16 year hypertension .</brief_summary>
	<brief_title>A Study Effectiveness Safety Ramipril Treatment Hypertension Children Adolescents</brief_title>
	<detailed_description>Information need treatment hypertension child adolescent antihypertensive drug like ramipril . The study assess safety blood pressure effect several dos antihypertensive drug ramipril child adolescent age 6-16 year . Approximately 450 child give placebo , 1 3 dos ramipril . The treatment assign do chance , like flip coin . Approximately 120 study center throughout world participate trial . Each child complete 1- 4-week Screening Period stop take current blood pressure lower drug ( ) , 4-week Treatment Period receive placebo one ramipril dose , Follow-up visit 1 week completion Treatment Period . Children diagnose hypertension accord fourth report diagnosis , evaluation treatment high blood pressure child adolescent ( U.S. report ) , include study blood pressure meet certain value . Each child complete minimum 6 9 clinic visit course study procedures assessment blood pressure safety perform . In addition , child 's parents/guardians instructed measure child 's blood pressure home clinic visit . A planned interim analysis perform approximately 240 subject complete trial . The study stop , permit protocol , analysis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>1 . Previous , documented diagnosis hypertension , newly diagnose hypertension accord fourth report diagnosis , evaluation treatment high blood pressure child adolescent ( United States ) . SiSBP great equal 95th percentile age , gender , height . 2 . The subject safely withdrawn antihypertensive medication screen period , give placebo treatment period judgment Investigator . 3 . The subject male female age 6 16 year ( inclusive ) , weigh great equal 20 kg . 4 . Female subject great equal 12 year age , great equal 1 menstruation must : ( ) negative serum pregnancy test screening ( i.e. , subject pregnant ) , ( b ) lactating , ( c ) use acceptable method contraception . 5 . Parents/guardians able demonstrate ability ( ) use home blood pressure monitor supply study monitor child 's blood pressure , ( 2 ) mix administer liquid dose study drug need . 1 . Bilateral renal artery stenosis . 2 . Uncorrected coarctation aorta correct coarctation right arm/right leg blood pressure gradient great 10 mmHg . 3 . Severe hypertension . 4 . Renal transplantation previous solid organ transplantation le 6 month prior enter study . 5 . Subjects nephrotic syndrome stable maintenance therapy prednisone cyclosporine . 6 . A history cardiomyopathy , clinically significant structural heart disease , atrioventricular conduction disturbance , sick sinus syndrome , atrial flutter , atrial fibrillation , clinically significant bradycardia accessory bypass tract , clinical symptom congestive heart failure . 7 . Clinically significant hematologic , hepatobiliary , renal disease include Schwartz formula GFR le 40 mL/min/1.73 m2 , and/or serum potassium ( K+ ) great 5.5 mEq/L . 8 . History pancreatitis ( active inactive ) . 9 . Known sensitivity angiotensin convert enzyme inhibitor history angioneurotic edema .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Hypertension/*etiology</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Adolescent</keyword>
	<keyword>Child</keyword>
</DOC>